HUTCHMED (China) Limited (HCM.L) Stock Price
£205 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on HUTCHMED (China) Limited, AI stock picks, stock alerts and much more.
HCM.L AI Stock Analysis
AI stock analysis for HCM.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like HUTCHMED (China) Limited (HCM.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
HUTCHMED (China) Limited (HCM.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of HUTCHMED (China) Limited (HCM.L), currently trading at £205, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About HCM.L
-
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally.
-
Symbol
HCM.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
1.8B
Similar Stocks
 |
Shield Therapeutics STX.L |
£2.35 2.1% |
4 |
 |
Indivior PLC INDV.L |
£844.5 2.3% |
5 |
 |
Haleon plc HLN.L |
£404 0.6% |
7 |
 |
Hikma Pharmaceuticals PLC HIK.L |
£2070 0.7% |
7 |
 |
Alliance Pharma APH.L |
£64.7 0% |
7 |
News
-limited-logo-1200x675.png?v=20221128134910&w=240&h=240&zc=2){kind=logo}
HCM.L Alternative Data
Web Traffic
HUTCHMED (China) Limited receives an estimated 39913 monthly visitors to hutch-med.com.
-
Web Traffic
39913
-
Change from Previous Month
270.6%
-
3 Month Change
232.6%
-
YoY Change
232.6%
Twitter Followers
HUTCHMED (China) Limited has 267 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
267
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3.5%
Job Postings
HUTCHMED (China) Limited currenly has an estimated 10 open job postings, up by 25% over the last month.
-
Job Postings
10
-
Daily Change
0%
-
1 Month Change
25%
-
3 Month Change
11.1%
Reddit Mentions
HUTCHMED (China) Limited has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Employees
According to LinkedIn, HUTCHMED (China) Limited has 668 employees, up by 0.5% over the last month.
-
LinkedIn Employees
668
-
Daily Change
0.5%
-
1 Month Change
0.5%
-
3 Month Change
1.2%
News Mentions
HUTCHMED (China) Limited was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at HUTCHMED (China) Limited is 73 out of 100 (bullish).
-
Business Outlook
73
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
HCM.L Financials
HCM.L Key Metrics
-
Total Revenue
$152.8M
-
Net Income
$12.9M
-
Earnings per Share
$0.015
-
Free cash flow
-$25M
-
EBITDA
-$10.6M
-
EBITDA Ratio
-0.0695791
-
Total Assets
$1.3B
HCM.L 2-year Revenue & Income
HCM.L 2-year Free Cash Flow
HCM.L Technicals
HCM.L SMA
HCM.L RSI
FAQ
What's the current price of HUTCHMED (China) Limited (HCM.L) Stock?
The price of an HUTCHMED (China) Limited (HCM.L) share is £205.
What's the market cap of HUTCHMED (China) Limited?
The current market cap of HUTCHMED (China) Limited is 1.8B.
Should I buy or sell HCM.L?
HUTCHMED (China) Limited shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, HUTCHMED (China) Limited is better viewed as a hold or accumulate position while waiting for further developments.
Is HUTCHMED (China) Limited a good investment?
The current analysis of HUTCHMED (China) Limited's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in HUTCHMED (China) Limited's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy HUTCHMED (China) Limited (HCM.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for HUTCHMED (China) Limited stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to HUTCHMED (China) Limited (HCM.L) that investors often compare it to?
HUTCHMED (China) Limited (HCM.L) is often compared to similar stocks such as Shield Therapeutics, Indivior PLC, Haleon plc, Hikma Pharmaceuticals PLC and Alliance Pharma.
What is the forecast for HUTCHMED (China) Limited's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast HUTCHMED (China) Limited's stock price to be around £197.9 in 2026. Starting from the current price of £205, this represents a 3.4% change in price, indicating a neutral outlook for the stock.
How to buy HUTCHMED (China) Limited (HCM.L) Stock?
HUTCHMED (China) Limited stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy HUTCHMED (China) Limited shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.